These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8632711)

  • 21. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.
    Salmi P; Karlsson T; Ahlenius S
    Eur J Pharmacol; 1994 Feb; 253(1-2):67-73. PubMed ID: 7912199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism.
    Chung YC; Li Z; Dai J; Meltzer HY; Ichikawa J
    Brain Res; 2004 Oct; 1023(1):54-63. PubMed ID: 15364019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
    Ichikawa J; Dai J; O'Laughlin IA; Fowler WL; Meltzer HY
    Neuropsychopharmacology; 2002 Mar; 26(3):325-39. PubMed ID: 11850147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors.
    Robertson GS; Lee CJ; Sridhar K; Nakabeppu Y; Cheng M; Wang YM; Caron MG
    Eur J Neurosci; 2004 Dec; 20(11):3189-94. PubMed ID: 15579174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841.
    Krisch I; Bole-Vunduk B; Pepelnak M; Lavric B; Ocvirk A; Budihna MV; Sket D
    J Pharmacol Exp Ther; 1994 Oct; 271(1):343-52. PubMed ID: 7965734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia.
    Ikeda H; Adachi K; Hasegawa M; Sato M; Hirose N; Koshikawa N; Cools AR
    J Neural Transm (Vienna); 1999; 106(11-12):1205-16. PubMed ID: 10651114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol.
    Millan MJ; Schreiber R; Dekeyne A; Rivet JM; Bervoets K; Mavridis M; Sebban C; Maurel-Remy S; Newman-Tancredi A; Spedding M; Muller O; Lavielle G; Brocco M
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1356-73. PubMed ID: 9732399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics.
    Wirtshafter D
    Eur J Pharmacol; 1998 Oct; 358(3):R1-3. PubMed ID: 9822897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G; Bidzinski A; Fusi R; Ladinsky H; Consolo S
    Life Sci; 1987 Oct; 41(14):1717-23. PubMed ID: 2958667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of acute administration of haloperidol and clozapine on ethanol-induced ascorbic acid release in rat striatum.
    Liu W; Wu CF; Liu J; Huang M; Xiao K
    Eur J Pharmacol; 2000 Jun; 398(3):333-9. PubMed ID: 10862822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP.
    Altar CA; Boyar WC; Kim HS
    Eur J Pharmacol; 1990 May; 181(1-2):17-21. PubMed ID: 1974856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S; Watson E; Stanley ME
    J Pharmacol Exp Ther; 1975 Nov; 195(2):265-70. PubMed ID: 1185596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.